Massmutual Trust CO Fsb Uni Qure N.V. Transaction History

Massmutual Trust CO Fsb

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 06, 2023	BUY	$18.12 - $27.32 $1,214 - $1,830	67 New	67 $2,000
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $1,725 - $2,479	-59 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $494 - $709	-14 Reduced 19.18%	59 $2,000
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $2,626 - $3,479	73 New	73 $3,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.